Metraipolis › archive › dc_f274863fa93f
The efficacy and safety of darolutamide combination therapy in advanced prostate cancer: a systematic review and meta-analysis of randomized controlled trials — Europe PMC PMID:42232182
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42232182
- DOI
- 10.3389/fphar.2026.1818807
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T15:31:42.384Z
- SHA-256 of the archived text
deac4b72a6cd91c4c29ec9c9fcc03cd8e0f5417b3017eacacff2667a62c8abd7- Stable URL of this page
https://metraipolis.com/documento/dc_f274863fa93f
How to cite
The efficacy and safety of darolutamide combination therapy in advanced prostate cancer: a systematic review and meta-analysis of randomized controlled trials — Europe PMC PMID:42232182 — Europe PMC (en), https://europepmc.org/article/MED/42232182 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f274863fa93f (Metraipolis archive dc_f274863fa93f, sha256 deac4b72a6cd91c4c29ec9c9fcc03cd8e0f5417b3017eacacff2667a62c8abd7)
BibTeX
@misc{dcf274863fa93f,
title = {The efficacy and safety of darolutamide combination therapy in advanced prostate cancer: a systematic review and meta-analysis of randomized controlled trials — Europe PMC PMID:42232182},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42232182},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f274863fa93f; sha256 deac4b72a6cd91c4c29ec9c9fcc03cd8e0f5417b3017eacacff2667a62c8abd7},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42232182. Agents can read the archived copy with the MCP tool read_document.